Table 1.

Baseline characteristics according to coagulation status: Group I (low anticoagulation status) included patients with both INR below 2.0 and aPTT ratio below 1.50; Group II (adequate anticoagulation status) included patients with either INR ≥ 2.0 or aPTT ratio ≥ 1.50

	Overall	Coagulation status at the time of event			Coagulation status two weeks prior of event
	(n = 38) median (Q1-Q3)	Group I (n = 12)	Group II (n = 26)	p	Group I (n = 8)	Group II (n = 30)	p
Age	45 (36–54)	46	44	.94	45	45	.71
Male sex (%)	25 (66 %)	7 (58 %)	18 (69 %)	.71	4 (50 %)	21 (70 %)	.41
Smoking (%)	24 (63 %)	7 (58 %)	17 (65 %)	.73	6 (75 %)	18 (60 %)	.68
Diabetes (%)	2 (5 %)	1 (8 %)	1 (4 %)	.54	0	2 (7 %)	1.0
Hypertension (%)	4 (11 %)	0	4 (15 %)	.29	0	4 (13 %)	.56
Hypercholesterolemia (%)	10 (26 %)	4 (33 %)	6 (23 %)	.69	3 (38 %)	7 (23 %)	.41
Prior MI (%)	5 (13 %)	1 (8 %)	4 (15 %)	.99	2 (25 %)	3 (10 %)	.28
Prior stroke (%)	4 (11 %)	2 (17 %)	2 (8 %)	.58	0	4 (13 %)	.56
Ischemic heart disease (%)	12 (32 %)	3 (25 %)	9 (35 %)	.71	5 (63 %)	7 (23 %)	.08
Hemoglobin	7.2 (6.5–7.9)	7.0	7.5	.23	6.4	7.4	.10
Leukocyte count	10.8 (8.3–13.9)	10.2	10.8	.75	8.5	10.8	.18
Platelet count	219 (164–296)	168	226	.34	192	226	.77
Creatinin	117 (96–150)	103	120	.11	119	114	.54
Blood urea nitrogen	10.6 (7.4–15.3)	90	11.8	.15	9.2	11.8	.31
ASAT	66 (32–192)	42	77	.24	126	62	.99
ALAT	71 (38–216)	53	77	.31	64	71	.57
LDH	481 (297–726)	354	542	.04	465	504	.68
Cardiac index	1.78 (1.50–2.01)	1.81	1.70	.77	1.86	1.69	.45
IABP treatment (%)	4 (11 %)	2 (17 %)	2 (8 %)	.58	1 (13 %)	3 (10 %)	.99
Temporary VAD (%)	4 (11 %)	2 (17 %)	2 (8 %)	.58	2 (25 %)	2 (7 %)	.19
Concomitant RVAD	0	0	0	-	0	0	-